In order to identify RB1 synthetic lethal targets, we conducted chemical and genetic vulnerability screenings using epigenetics-focused small molecules and RNAi libraries in RB1-isogenic lung cancer cells. This evidence concerns the gene RB1 and lung carcinoma.